Literature DB >> 20719374

Invariant natural killer T cells and asthma: immunologic reality or methodologic artifact?

Collin R Brooks, Robert Weinkove, Ian F Hermans, Christine J van Dalen, Jeroen Douwes.   

Abstract

Mesh：

Year:  2010        PMID： 20719374     DOI： 10.1016/j.jaci.2010.06.041

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

Review 1.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 2.  The role of invariant T cells in inflammation of the skin and airways.

Authors:  Kwok Ho Yip; Magdalene Papadopoulos; Harshita Pant; Damon J Tumes
Journal:  Semin Immunopathol       Date:  2019-04-15       Impact factor: 9.623

3.  Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.

Authors:  Robert Weinkove; Collin R Brooks; John M Carter; Ian F Hermans; Franca Ronchese
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

4.  Natural killer T cells: drivers or passengers in preventing human disease?

Authors:  Stuart P Berzins; David S Ritchie
Journal:  Nat Rev Immunol       Date:  2014-08-08       Impact factor: 53.106

5.  NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma.

Authors:  Christopher G McKnight; Suzanne C Morris; Charles Perkins; Zhenqi Zhu; David A Hildeman; Albert Bendelac; Fred D Finkelman
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

Review 6.  Role of CD1d- and MR1-Restricted T Cells in Asthma.

Authors:  Chiaki Iwamura; Toshinori Nakayama
Journal:  Front Immunol       Date:  2018-08-28       Impact factor: 7.561

Review 7.  Lipid-Reactive T Cells in Immunological Disorders of the Lung.

Authors:  Seungwon Ryu; Joon Seok Park; Hye Young Kim; Ji Hyung Kim
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.